Glad to be part of this board. Nothing to worry here. We know 20+ million international deal is already in place. It means they don't have to go through sales process and don't have to worry if someone will buy a product. The buyer likes the product and has offered huge sums of money for it. We only have to wait until approval comes in various countries which is taking time. The sales are booked but they can't sign definitive agreement until approval is done which makes sense.
We have multiple sales channels opened up through which we can sell product Mayo clinic, NYC and other avenues.
As for share structure yes it is increased and hard to watch it grow but in the end this will be worth minimum ten bagger even if you dilute all 125M shares. Biotech stocks run hard when times are good and some have P/E > 20 if that happens $1 will be history. JMO
News 
Market Data 
Discover 
